Murae Organisor Ltd Stock Hits All-Time Low Amidst Prolonged Downtrend

Feb 01 2026 09:34 AM IST
share
Share Via
Shares of Murae Organisor Ltd, a player in the Pharmaceuticals & Biotechnology sector, have declined to a historic low of Rs.0.2, marking a significant milestone in the stock’s extended downward trajectory despite recent positive earnings reports.
Murae Organisor Ltd Stock Hits All-Time Low Amidst Prolonged Downtrend

Stock Performance Overview

On 1 Feb 2026, Murae Organisor Ltd reached a new 52-week and all-time low price of Rs.0.2. This level reflects a stark contrast to the broader market, with the Sensex showing a marginal decline of 0.02% on the same day, while Murae Organisor’s stock recorded a 5.00% gain intraday, outperforming its sector by 4.41%. However, this short-term uptick belies a much longer-term decline.

Over the past year, the stock has plummeted by 89.34%, significantly underperforming the Sensex, which gained 7.16% during the same period. The three-year and five-year returns are even more pronounced, with losses of 89.56% and 96.95% respectively, compared to Sensex gains of 38.25% and 77.71%. The stock’s 10-year performance remains flat at 0.00%, while the Sensex soared by 230.74%.

Shorter-term trends also indicate sustained weakness. The one-month and three-month performances are identical at -22.22%, far worse than the Sensex’s modest declines of 2.86% and 2.54%. Year-to-date, the stock has fallen 19.23%, compared to a 3.48% drop in the benchmark index.

Technical indicators show Murae Organisor trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – underscoring the persistent bearish momentum.

Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!

  • - New profitability achieved
  • - Growth momentum building
  • - Under-the-radar entry

Get In Before Others →

Financial Metrics and Fundamental Assessment

Murae Organisor’s financial profile presents a complex picture. The company has reported positive earnings growth in recent quarters, with net profit rising by 161.05% in June 2025 and positive results declared for four consecutive quarters. Net sales for the latest six months stood at Rs.519.52 crores, reflecting an extraordinary growth rate of 225,778.26%. Quarterly profit after tax (PAT) reached Rs.7.44 crores, a 295.7% increase compared to the previous four-quarter average, while earnings per share (EPS) peaked at Rs.0.07.

Despite these encouraging earnings figures, the company’s long-term fundamental strength remains weak. It has not declared financial results for the last six months, which raises concerns about transparency and reporting consistency. The debt servicing capacity is notably strained, with a high Debt to EBITDA ratio of 8.43 times, indicating significant leverage and potential difficulties in meeting financial obligations.

Return on Capital Employed (ROCE) is low at 0.4, yet the valuation metrics suggest a very attractive enterprise value to capital employed ratio of 0.6. The stock is trading at a discount relative to its peers’ average historical valuations, which may reflect market apprehension about the company’s financial health and growth sustainability.

Market Capitalisation and Ownership Structure

The company holds a Market Cap Grade of 3, indicating a relatively modest market capitalisation within its sector. Majority shareholding is held by non-institutional investors, which may influence liquidity and trading dynamics. The Mojo Score stands at 37.0, with a current Mojo Grade of Sell, downgraded from Hold on 25 Aug 2025, reflecting a deteriorated outlook based on MarketsMOJO’s comprehensive analysis.

Holding Murae Organisor Ltd from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Sector and Industry Context

Murae Organisor operates within the Pharmaceuticals & Biotechnology sector, a space characterised by innovation, regulatory scrutiny, and competitive pressures. While the sector has generally shown resilience and growth, Murae Organisor’s stock performance diverges sharply from sector averages, reflecting company-specific factors rather than broader industry trends.

The stock’s recent outperformance relative to its sector on the day of the all-time low is a technical anomaly rather than a reversal signal, given the prevailing downtrend across multiple time frames and moving averages.

Summary of Key Challenges

The stock’s historic low price is underpinned by several factors: a prolonged decline over multiple years, weak long-term fundamentals, high leverage, and a lack of recent financial disclosures. Despite recent quarterly profit growth and sales expansion, these positives have not translated into sustained investor confidence or price recovery.

The company’s ability to service debt remains a critical concern, with a Debt to EBITDA ratio exceeding 8 times, signalling elevated financial risk. The low ROCE further highlights limited efficiency in capital utilisation.

Trading below all major moving averages and a downgraded Mojo Grade to Sell reinforce the subdued market sentiment surrounding Murae Organisor Ltd.

Conclusion

Murae Organisor Ltd’s stock reaching an all-time low of Rs.0.2 marks a significant event in its market journey, reflecting a combination of financial strain and extended price weakness. While recent earnings growth and sales expansion offer some positive data points, the overall financial and market context remains challenging. The stock’s valuation discount relative to peers and attractive enterprise value metrics coexist with concerns over debt levels and reporting gaps, resulting in a cautious outlook as reflected in its current Mojo Grade.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News